交易 Finch Therapeutics Group, Inc. - FNCH CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.1324 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 0.001 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Finch Therapeutics Group Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Mar 28, 2024 | 2.6238 | 0.0000 | 0.00% | 2.6238 | 2.6238 | 2.6238 |
Mar 27, 2024 | 2.7338 | 0.0000 | 0.00% | 2.7338 | 2.7338 | 2.6738 |
Mar 26, 2024 | 2.4838 | -0.0700 | -2.74% | 2.5538 | 2.5538 | 2.4838 |
Mar 25, 2024 | 2.6838 | 0.1000 | 3.87% | 2.5838 | 2.6838 | 2.5838 |
Mar 22, 2024 | 2.5438 | 0.0100 | 0.39% | 2.5338 | 2.5438 | 2.5338 |
Mar 21, 2024 | 2.5938 | -0.0900 | -3.35% | 2.6838 | 2.7138 | 2.5938 |
Mar 20, 2024 | 2.6638 | 0.0100 | 0.38% | 2.6538 | 2.6738 | 2.6538 |
Mar 18, 2024 | 2.6838 | 0.1900 | 7.62% | 2.4938 | 2.7838 | 2.4938 |
Mar 15, 2024 | 2.4838 | 0.0000 | 0.00% | 2.4838 | 2.5438 | 2.4738 |
Mar 14, 2024 | 2.4838 | 0.0600 | 2.48% | 2.4238 | 2.5338 | 2.4238 |
Mar 13, 2024 | 2.5238 | -0.0800 | -3.07% | 2.6038 | 2.8138 | 2.4238 |
Mar 12, 2024 | 2.6538 | -0.3400 | -11.36% | 2.9938 | 2.9938 | 2.6338 |
Mar 11, 2024 | 3.3838 | 0.8500 | 33.55% | 2.5338 | 4.3638 | 2.5338 |
Mar 8, 2024 | 2.3638 | 0.0000 | 0.00% | 2.3638 | 2.3638 | 2.3638 |
Mar 7, 2024 | 2.3838 | -0.1000 | -4.03% | 2.4838 | 2.4838 | 2.2838 |
Mar 6, 2024 | 2.4738 | 0.0800 | 3.34% | 2.3938 | 2.4738 | 2.3938 |
Mar 5, 2024 | 2.4338 | -0.1600 | -6.17% | 2.5938 | 2.5938 | 2.4238 |
Mar 4, 2024 | 2.6138 | -0.0900 | -3.33% | 2.7038 | 2.8038 | 2.6138 |
Mar 1, 2024 | 2.7338 | 0.0400 | 1.48% | 2.6938 | 2.7338 | 2.6938 |
Feb 29, 2024 | 2.5838 | 0.0600 | 2.38% | 2.5238 | 2.6138 | 2.5238 |
Finch Therapeutics Group, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
沒有活動安排 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
總收入 | 0.861 | 18.532 | 7.719 | 10.154 |
收入 | 0.861 | 18.532 | 7.719 | 10.154 |
收入成本,共計 | 0 | 0.314 | ||
毛利 | 7.719 | 9.84 | ||
總營業費用 | 116.454 | 76.69 | 47.155 | 31.296 |
銷售/一般/行政費用,總計 | 38.088 | 21.238 | 14.011 | 7.439 |
研究與開發 | 57.893 | 57.279 | 33.144 | 23.543 |
營業收入 | -115.593 | -58.158 | -39.436 | -21.142 |
利息收入(費用),非經營淨值 | 0.252 | 0.022 | 0.106 | 0.488 |
Gain (Loss) on Sale of Assets | -0.007 | 0.028 | -0.013 | -0.14 |
其他,淨值 | 0.702 | -0.052 | 0.002 | 0.04 |
稅前淨收入 | -114.646 | -58.16 | -39.341 | -20.754 |
稅後淨收入 | -114.646 | -58.16 | -39.341 | -20.754 |
未計算非常項目前的淨收益 | -114.646 | -58.16 | -39.341 | -20.754 |
淨收入 | -114.646 | -58.16 | -39.341 | -20.754 |
普通股股東可獲收益 (不含非經常性項目) | -114.646 | -58.16 | -39.341 | -20.754 |
普通股股東可獲收益 (含非經常性項目) | -114.646 | -58.16 | -39.341 | -20.754 |
攤薄淨收入 | -114.646 | -58.16 | -39.341 | -20.754 |
攤薄後加權平均股 | 1.58972 | 1.30661 | 1.57136 | 1.57136 |
扣除特別項目的每股攤薄盈利 | -72.1171 | -44.5123 | -25.0363 | -13.2077 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | ||
每股正常攤薄盈利 | -54.8939 | -45.932 | -25.0281 | -13.1186 |
異常費用(收入) | 20.473 | -1.827 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0.107 | 0.008 | 0.138 | 0.361 |
收入 | 0 | 0.107 | 0.008 | 0.138 | 0.361 |
總營業費用 | 9.129 | 67.256 | 27.76 | 40.77 | 22.99 |
銷售/一般/行政費用,總計 | 8.877 | 9.617 | 10.936 | 9.584 | 8.164 |
研究與開發 | 0.203 | 6.996 | 16.581 | 11.859 | 13.923 |
營業收入 | -9.129 | -67.149 | -27.752 | -40.632 | -22.629 |
利息收入(費用),非經營淨值 | 0.42 | 0.425 | 0.259 | 0.045 | -0.065 |
其他,淨值 | 1.005 | 1.053 | 0.486 | 0.216 | 0 |
稅前淨收入 | -6.95 | -65.808 | -27.008 | -40.371 | -22.7 |
稅後淨收入 | -6.95 | -62.347 | -27.008 | -40.371 | -22.7 |
未計算非常項目前的淨收益 | -6.95 | -62.347 | -27.008 | -40.371 | -22.7 |
淨收入 | -6.95 | -62.347 | -27.008 | -40.371 | -22.7 |
普通股股東可獲收益 (不含非經常性項目) | -6.95 | -62.347 | -27.008 | -40.371 | -22.7 |
普通股股東可獲收益 (含非經常性項目) | -6.95 | -62.347 | -27.008 | -40.371 | -22.7 |
攤薄淨收入 | -6.95 | -62.347 | -27.008 | -40.371 | -22.7 |
攤薄後加權平均股 | 1.6048 | 1.6043 | 1.5977 | 1.59078 | 1.58572 |
扣除特別項目的每股攤薄盈利 | -4.33077 | -38.8624 | -16.9043 | -25.3781 | -14.3153 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -4.77008 | -18.2883 | -16.7516 | -13.2287 | -13.742 |
異常費用(收入) | 0.049 | 50.643 | 0.243 | 19.327 | 0.903 |
Gain (Loss) on Sale of Assets | 0.754 | -0.137 | -0.001 | 0 | -0.006 |
Other Operating Expenses, Total | 0 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
流動資産總額 | 74.551 | 142.551 | 106.164 | 48.626 |
現金和短期投資 | 71.038 | 133.481 | 99.71 | 42.186 |
現金等價物 | 71.038 | 133.481 | 99.71 | 42.186 |
應收賬款總額,淨額 | 0.144 | 0.494 | 1.095 | 4.746 |
應收賬款 - 貿易,淨額 | 0.144 | 0.494 | 1.034 | 1.178 |
預付的費用 | 3.369 | 8.576 | 5.359 | 1.694 |
總資産 | 162.939 | 225.369 | 165.338 | 103.569 |
物業/廠房/設備,總計 - 淨額 | 48.688 | 24.688 | 7.004 | 3.776 |
物業/廠房/設備,總計 - 總額 | 57.974 | 28.914 | 9.033 | 5.034 |
累計折舊,總計 | -9.286 | -4.226 | -2.029 | -1.258 |
商譽,淨額 | 0 | 18.057 | 18.057 | 18.057 |
無形資産,淨額 | 32.9 | 32.9 | 32.9 | 32.9 |
其他長期資産,總計 | 6.8 | 7.173 | 1.213 | 0.21 |
流動負債總額 | 14.689 | 14.79 | 11.486 | 7.325 |
應付賬款 | 1.097 | 3.737 | 2.621 | 0.655 |
預提費用 | 13.592 | 11.053 | 5.228 | 3.958 |
應付票據/短期債務 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0 | 3.637 | 2.712 | |
負債總額 | 67.228 | 23.145 | 28.002 | 19.954 |
長期債務總額 | 14.653 | 0.007 | 1.808 | 0 |
長期債務 | 14.653 | 0 | 1.808 | 0 |
遞延所得稅 | 3.461 | 3.461 | 3.461 | 3.461 |
其他負債,總計 | 34.425 | 4.887 | 11.247 | 9.168 |
股權 | 95.711 | 202.224 | 137.336 | 83.615 |
Redeemable Preferred Stock | 233.054 | 143.15 | ||
普通股 | 0.048 | 0.047 | 0.008 | 0.008 |
額外實收資本 | 371.304 | 363.172 | 7.109 | 3.951 |
留存收益(累計赤字) | -275.641 | -160.995 | -102.835 | -63.494 |
總負債和股東權益 | 162.939 | 225.369 | 165.338 | 103.569 |
已發行普通股總數 | 1.60163 | 1.58358 | 1.57136 | 1.57136 |
資本租賃義務 | 0 | 0.007 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 29.919 | 36.499 | 43.397 | 74.551 | 90.616 |
現金和短期投資 | 28.779 | 34.051 | 41.684 | 71.038 | 85.292 |
現金等價物 | 28.779 | 34.051 | 41.684 | 71.038 | 85.292 |
應收賬款總額,淨額 | 0 | 0 | 0.107 | 0.144 | 0 |
應收賬款 - 貿易,淨額 | 0 | 0 | 0.107 | 0.144 | 0 |
預付的費用 | 1.14 | 2.448 | 1.606 | 3.369 | 5.324 |
總資産 | 59.493 | 66.857 | 79.04 | 162.939 | 187.968 |
物業/廠房/設備,總計 - 淨額 | 27.226 | 28.04 | 33.075 | 48.688 | 57.635 |
物業/廠房/設備,總計 - 總額 | 27.458 | 28.286 | 35.351 | 57.974 | 65.956 |
累計折舊,總計 | -0.232 | -0.246 | -2.276 | -9.286 | -8.321 |
商譽,淨額 | 0 | 0 | |||
無形資産,淨額 | 0 | 0 | 0 | 32.9 | 32.9 |
其他長期資産,總計 | 2.348 | 2.318 | 2.568 | 6.8 | 6.817 |
流動負債總額 | 4.879 | 9.575 | 13.206 | 14.689 | 13.808 |
應付賬款 | 0.357 | 0.432 | 2.553 | 1.097 | 1.06 |
預提費用 | 4.522 | 9.143 | 10.653 | 13.592 | 12.748 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | |||||
負債總額 | 33.68 | 38.963 | 46.088 | 67.228 | 67.102 |
長期債務總額 | 0 | 0 | 0 | 14.653 | 14.636 |
長期債務 | 0 | 0 | 0 | 14.653 | 14.636 |
遞延所得稅 | 0 | 0 | 0 | 3.461 | 3.461 |
其他負債,總計 | 28.801 | 29.388 | 32.882 | 34.425 | 35.197 |
股權 | 25.813 | 27.894 | 32.952 | 95.711 | 120.866 |
Redeemable Preferred Stock | |||||
普通股 | 0.002 | 0.002 | 0.048 | 0.048 | 0.048 |
額外實收資本 | 373.165 | 372.83 | 372.484 | 371.304 | 369.451 |
留存收益(累計赤字) | -347.354 | -344.938 | -339.58 | -275.641 | -248.633 |
總負債和股東權益 | 59.493 | 66.857 | 79.04 | 162.939 | 187.968 |
已發行普通股總數 | 1.60503 | 1.60476 | 1.60467 | 1.60163 | 1.59406 |
資本租賃義務 | 0 | 0 | 0 | 0 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
淨收入/起跑線 | -114.646 | -58.16 | -39.341 | -20.754 |
經營活動産生的現金 | -74.851 | -67.133 | -31.329 | -17.32 |
經營活動産生的現金 | 5.507 | 2.301 | 0.79 | 0.482 |
非現金物品 | 35.852 | 3.238 | 3.112 | 0.746 |
已付現金利息 | 0.741 | 0.009 | 0.011 | 0.008 |
營運資金的變化 | -1.564 | -14.512 | 4.11 | 2.206 |
投資活動産生的現金 | -2.182 | -15.921 | -2.633 | -0.973 |
資本支出 | -2.182 | -15.983 | -2.633 | -1.005 |
其他投資現金流量項目,總計 | 0 | 0.062 | 0 | 0.032 |
融資活動産生的現金 | 14.873 | 119.11 | 91.475 | 53.3 |
融資現金流項目 | -0.132 | 0.39 | -0.249 | 0 |
股票的發行(報廢),淨額 | 0.289 | 118.747 | 89.963 | 48.571 |
債務的發行(退還),淨額 | 14.716 | -0.027 | 1.761 | 4.729 |
現金淨變化 | -62.16 | 36.056 | 57.513 | 35.007 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -63.939 | -114.646 | -87.638 | -47.267 | -24.567 |
Cash From Operating Activities | -13.381 | -74.851 | -60.579 | -41.485 | -25.646 |
Cash From Operating Activities | 1.367 | 5.507 | 4.099 | 2.694 | 1.331 |
Non-Cash Items | 49.749 | 35.852 | 26.117 | 4.959 | 2.362 |
Cash Interest Paid | 0.202 | 0.741 | 0.407 | 0.073 | 0.002 |
Changes in Working Capital | 2.903 | -1.564 | -3.157 | -1.871 | -4.772 |
Cash From Investing Activities | -0.014 | -2.182 | -2.131 | -1.803 | -0.909 |
Capital Expenditures | -0.014 | -2.182 | -2.131 | -1.803 | -0.909 |
Other Investing Cash Flow Items, Total | 0 | 0 | 0 | 0 | |
Cash From Financing Activities | -16.159 | 14.873 | 14.821 | 14.78 | 0.005 |
Financing Cash Flow Items | -1.155 | -0.132 | -0.132 | -0.132 | 0 |
Issuance (Retirement) of Stock, Net | 0 | 0.289 | 0.229 | 0.185 | 0.014 |
Issuance (Retirement) of Debt, Net | -15.004 | 14.716 | 14.724 | 14.727 | -0.009 |
Net Change in Cash | -29.554 | -62.16 | -47.889 | -28.508 | -26.55 |
Deferred Taxes | -3.461 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biotechnology & Medical Research (NEC) |
75 State Street
Suite 100
BOSTON
MASSACHUSETTS 02109
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易